Physician profile
Scott Schultz
NPI 1821098872
$93,786.28
in general payments reported to CMS, 2019-2025
20 companies · $4,280 in 2025
The $4,280 reported for 2025 was more than what 94% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $16K · 2021: $22K · 2022: $11K · 2023: $8,180 · 2024: $9,486 · 2025: $4,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $5,814 · Travel and Lodging: $83.32 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,025.00 |
| Food and Beverage | $5,813.97 |
| Travel and Lodging | $83.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $38,182.32 | 2019-2025 | Amplatzer Talisman, Jeti All In One Non-Sterile Kit, Esprit |
| Philips North America LLC | $33,201.27 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $9,446.72 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, C3 Delivery System |
| Boston Scientific Corporation | $3,888.21 | 2019-2025 | Angiojet Ultra 5000a, Ranger, General - Interventional Oncology |
| Medtronic Vascular, INC. | $3,061.24 | 2019-2020 | |
| Penumbra, INC. | $2,340.80 | 2019-2025 | Indigo System, Smart Coil, Penumbra System |
| Medtronic, INC. | $1,325.49 | 2021-2025 | Abre, Turbohawk, In.Pact Admiral |
| Bard Peripheral Vascular, INC. | $1,303.41 | 2019-2024 | Rotarexs 6 F X 135 Cm |
| Imperative Care, INC | $243.75 | 2022-2025 | Zoom 88-T Large Distal Platform |
| Silk Road Medical, INC. | $205.17 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Venturemed Group, INC. | $134.40 | 2021-2025 | Flex Vessel Prep System |
| Ge Healthcare | $119.68 | 2022 | |
| Shockwave Medical, INC | $94.52 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cordis US Corp. | $87.80 | 2023 | Brite Tip Radianz |
| Z-Medica, LLC | $58.86 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $23.81 | 2019 | |
| Abbvie INC. | $23.41 | 2025 | |
| Cook Medical LLC | $18.16 | 2019 | |
| Stryker Corporation | $14.12 | 2025 | Artix Mt |
| Medtronic USA, INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$10,600.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.